RELVAR ELLIPTA 184 microgrammes/22 microgrammes, poudre pour inhalation, en récipient unidose — 1 plaquette(s) aluminium de 30 dose(s) - 1 plaquette(s) de 30 dose(s) avec inhalateur(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400927620102
  • CIP7 2762010
  • CIS 61740809
  • Registration number EU/1/13/886

What the source publishes

Holder
GLAXOSMITHKLINE TRADING SERVICES (IRLANDE)
Active ingredients
FUROATE DE FLUTICASONE, VILANTÉROL, TRIFÉNATATE DE VILANTÉROL
Form
poudre et poudre pour inhalation
Package
1 plaquette(s) aluminium de 30 dose(s) - 1 plaquette(s) de 30 dose(s) avec inhalateur(s)
Routes
inhalée
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration de commercialisation
Authorised on
2013-11-13
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400927620102
{
  "cis": "61740809",
  "cip7": "2762010",
  "form": "poudre et  poudre pour inhalation",
  "name": "RELVAR ELLIPTA 184 microgrammes/22 microgrammes, poudre pour inhalation, en récipient unidose — 1 plaquette(s) aluminium de 30 dose(s) - 1 plaquette(s) de 30 dose(s) avec inhalateur(s)",
  "cip13": "3400927620102",
  "holder": "GLAXOSMITHKLINE TRADING SERVICES (IRLANDE)",
  "routes": [
    "inhalée"
  ],
  "holders": [
    "GLAXOSMITHKLINE TRADING SERVICES (IRLANDE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "29.40",
  "authorisedOn": "2013-11-13",
  "compositions": [
    {
      "name": "FUROATE DE FLUTICASONE",
      "nature": "SA",
      "strength": "184 microgrammes",
      "linkageNumber": "1",
      "substanceCode": "60723",
      "dosageReference": "une dose délivrée",
      "pharmaceuticalElement": "poudre de furoate de fluticasone"
    },
    {
      "name": "VILANTÉROL",
      "nature": "FT",
      "strength": "22 microgrammes",
      "linkageNumber": "3",
      "substanceCode": "31103",
      "dosageReference": "une dose délivrée",
      "pharmaceuticalElement": "poudre de vilantérol de trifénatate"
    },
    {
      "name": "TRIFÉNATATE DE VILANTÉROL",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "3",
      "substanceCode": "88617",
      "dosageReference": null,
      "pharmaceuticalElement": "poudre de vilantérol de trifénatate"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "28.38",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "RELVAR ELLIPTA 184 microgrammes/22 microgrammes, poudre pour inhalation, en récipient unidose",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "1 plaquette(s) aluminium de 30 dose(s) - 1 plaquette(s) de 30 dose(s) avec inhalateur(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65%"
  ],
  "marketingDeclaredOn": "2018-11-02",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "FUROATE DE FLUTICASONE",
    "VILANTÉROL",
    "TRIFÉNATATE DE VILANTÉROL"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/13/886",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400927620102"